Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »
Jennifer Maynard, associate professor and Laurence E. McMakin Jr. Centennial Fellow, has been awarded the prestigious title of Emerging Inventor of the Year by The University of Texas at Austin’s Office of Technology and Commercialization (OTC).
The Emerging Inventor of the Year award is a new award category within OTC’s 2015 Inventor of the … Read the rest »
Undergraduate Alex Prybutok won second place in the Division of Food, Pharmaceuticals, and Biotechnology Poster Competition at the American Institute of Chemical Engineers Annual Meeting in Atlanta.
Alex’s winning poster featured research she is conducting in Dr. Jennifer Maynard’s labto improve therapeutics to fight pertussis, more commonly known as Whooping Cough. Each year … Read the rest »
Abby Bassett was only four weeks old when what seemed to be a mild cold turned into a much harsher reality.
The newborn was diagnosed with pertussis, or whooping cough, a disease that claims the lives of 195,000 children across the globe annually.
Now, Jennifer Maynard, an associate professor in the McKetta Department … Read the rest »
Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.
Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Recent reports … Read the rest »